Fritextsökning
Innehållstyper
-
Kim Ramme tar över som forskningschef på Barncancerfonden
Kim Ramme är barnläkare och specialist inom barnhematologi och barnonkologi med särskilt fokus på stamcellsbehandlingar. Nu blir hon ny forskningschef på Barncancerfonden.
-
Extremely high sample throughput rates
Precision and reliability in automated liquid handling
-
Gothenburg, the city of life science – We are ‘Little Boston’
Western Sweden is investing in life science within everything from advanced therapeutic drugs to femtech. At the same time, stakeholders are looking to other in...
-
Sofia Wallström is Lif's new CEO
Sofia Wallström has been appointed as the new CEO of the industry organization Lif, the trade association for the research-based pharmaceutical industry in Sweden.
-
Bayer has cut 1,500 roles – so far
German chemical and pharmaceutical group Bayer cut more than 1,500 roles in the first quarter alone– and most of them were management positions.
-
Danish obesity success causes recruitment problems in southern Sweden
The substantial expansion of Danish Novo Nordisk is affecting companies in southern Sweden, which are finding it increasingly difficult to compete for attractive staff.
-
Lennart Jungersten blir vd för Boehringer Ingelheim Sverige
Lennart Jungersten har i i över ett decennium arbetat för Boehringer Ingelheim i olika länder och på olika kontinenter. Nu återvänder han hem och utses till vd ...
-
Studie: Reningsverk en bov i utvecklingen av antibiotikaresistens
hjälp av en AI-modell.
-
Fast Optical Sectioning of Developing Organisms and Tissue Microstructures
ZEISS Lattice SIM 3 exploits the full potential of the SIM Apotome technology.
-
AI-företag köper tillgång till vetenskapliga studier – ”Svårt att reagera som forskare”
Stora förlag för vetenskapliga tidskrifter har i miljonaffärer sålt tillgång till studier till techbolag som utvecklar AI-verktyg. Reaktionerna bland svenska fo...
-
Medivir CEO on upcoming study: ”It's about working together with others”
are about working together with others," says the company's CEO Jens Lindberg.
-
Ålder som hinder – Så hittar du nya jobbmöjligheter efter 55
Trots lång erfarenhet har många svårt att ta sig vidare i karriären efter 55. Karriärcoachen Tina Persson råder att lyfta fram överförbara kunskaper och att vår...
-
From Valneva to the CEO position at NorthX – “I saw it as a great opportunity”
at NorthX Biologics – under the direction of new CEO Janet Hoogstraate.
-
Who pays for Rebecca Doe – and all of us?
Anna Törner on how easily we get used to the idea that healthcare is free - when it really is about how and who pays for it
-
New moves around Nykode's management – withdrawal of resignations
Norwegian Nykode Therapeutics is reinstating members of the management team who previously announced their resignations.
-
Discover Precision: Join ZEISS at the Control Fair in Stuttgart
May 6-9, 2025 in Stuttgart. Hall 9, Booth 9309.
-
Study: Chat GPT is more empathetic than doctors
The AI tool Chat GPT is not only more accurate when it comes to answering patient questions – the chatbot is also perceived as almost 10 times more empathetic than real doctors, a ...
-
Several departures at the top at Nykode
Members of both the management and the board are leaving the Norwegian biotech company Nykode.
-
Medical Plastics Tips & Tricks
Measuringhero video by ZEISS.
-
Anna Törner: Kalashnikovs in a new guise
Thanks to resisting European regulatory authorities, Europe has been spared the opioid epidemic. In the 1960s, the situation was the opposite as the American ph...
-
A new scientific event in Gothenburg
Life Science Sweden is holding an event in Gothenburg for the first time.
-
The US is leaving the WHO
The newly installed US President, Donald Trump, has issued an executive order for the US to leave the World Health Organization, WHO.
-
“An entire industry is about to be wiped out”
According to Jennie Ekbeck, CEO of Umeå Biotech Incubators, Sweden risks not having any small diagnostic companies left in five years.
-
Nobelpristagare spår första AI-läkemedlet redan nästa år
De första AI-utvecklade läkemedlen kan börja prövas redan mot slutet av året. Det säger Demis Hassabis, Googles chef för Deepmind och medgrundare till Isomorphic Labs.
BREAKING